XELB Fundamental Analysis - XCEL BRANDS INC

Name: XCEL BRANDS INC (XELB) Stock
Brand: XCEL BRANDS INC
Rating: 3 (3 reviews)

Fundamental Rating

Taking everything into account, XELB scores 1 out of 10 in our fundamental rating. XELB was compared to 122 industry peers in the Specialty Retail industry. Both the profitability and financial health of XELB have multiple concerns. XELB does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

XELB had negative earnings in the past year.

In the past year XELB has reported a negative cash flow from operations.

In the past 5 years XELB always reported negative net income.

In the past 5 years XELB reported 4 times negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -48.91%, XELB is doing worse than 92.62% of the companies in the same industry.

XELB's Return On Equity of -94.11% is on the low side compared to the rest of the industry. XELB is outperformed by 72.95% of its industry peers.

		Industry Rank	Sector Rank
ROA	-48.91%
ROE	-94.11%
ROIC	N/A

ROA(3y)-25.19%

ROA(5y)-19.15%

ROE(3y)-40.45%

ROE(5y)-30.57%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

XELB's Gross Margin of 135.33% is amongst the best of the industry. XELB outperforms 100.00% of its industry peers.

In the last couple of years the Gross Margin of XELB has grown nicely.

The Profit Margin and Operating Margin are not available for XELB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	135.33%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.58%

GM growth 5Y4.65%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

XELB does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, XELB has less shares outstanding

Compared to 5 years ago, XELB has less shares outstanding

XELB has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -2.86, we must say that XELB is in the distress zone and has some risk of bankruptcy.

XELB's Altman-Z score of -2.86 is on the low side compared to the rest of the industry. XELB is outperformed by 87.70% of its industry peers.

A Debt/Equity ratio of 0.48 indicates that XELB is not too dependend on debt financing.

With a Debt to Equity ratio value of 0.48, XELB perfoms like the industry average, outperforming 53.28% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.48
Debt/FCF	N/A
Altman-Z	-2.86

ROIC/WACCN/A

WACC10.35%

2.3 Liquidity

XELB has a Current Ratio of 0.59. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.

XELB's Current ratio of 0.59 is on the low side compared to the rest of the industry. XELB is outperformed by 91.80% of its industry peers.

XELB has a Quick Ratio of 0.59. This is a bad value and indicates that XELB is not financially healthy enough and could expect problems in meeting its short term obligations.

XELB's Quick ratio of 0.59 is in line compared to the rest of the industry. XELB outperforms 55.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.59
Quick Ratio	0.59

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.50% over the past year.

XELB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -53.48%.

XELB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -27.67% yearly.

EPS 1Y (TTM)8.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-236.67%

Revenue 1Y (TTM)-53.48%

Revenue growth 3Y-39.84%

Revenue growth 5Y-27.67%

Sales Q2Q%-41.42%

3.2 Future

Based on estimates for the next years, XELB will show a small growth in Earnings Per Share. The EPS will grow by 3.79% on average per year.

XELB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.31% yearly.

EPS Next Y-41.64%

EPS Next 2Y4.25%

EPS Next 3Y3.79%

EPS Next 5YN/A

Revenue Next Year-38.17%

Revenue Next 2Y4.54%

Revenue Next 3Y-9.31%

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

XELB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year XELB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y4.25%

EPS Next 3Y3.79%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

XELB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

XCEL BRANDS INC

NASDAQ:XELB (11/19/2025, 2:55:18 PM)

0.8045

-0.04 (-4.23%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Discretionary Distribution & Retail

GICS IndustrySpecialty Retail

Earnings (Last)11-19 2025-11-19/amc

Earnings (Next)N/A N/A

Inst Owners14.68%

Inst Owner Change28.18%

Ins Owners32.49%

Ins Owner Change59.34%

Market Cap3.87M

Revenue(TTM)8.26M

Net Income(TTM)-23.08M

Analysts82.5

Price Target5.1 (533.93%)

Short Float %4.94%

Short Ratio0.16

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)12.03%

Min EPS beat(2)-3.39%

Max EPS beat(2)27.45%

EPS beat(4)3

Avg EPS beat(4)26.9%

Min EPS beat(4)-3.39%

Max EPS beat(4)54.75%

EPS beat(8)7

Avg EPS beat(8)36.96%

EPS beat(12)9

Avg EPS beat(12)23.28%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-36.32%

Min Revenue beat(2)-43.05%

Max Revenue beat(2)-29.58%

Revenue beat(4)1

Avg Revenue beat(4)-25.67%

Min Revenue beat(4)-43.05%

Max Revenue beat(4)7.72%

Revenue beat(8)1

Avg Revenue beat(8)-16%

Revenue beat(12)3

Avg Revenue beat(12)-8.58%

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-21.05%

PT rev (3m)-58.33%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-491.67%

EPS NY rev (1m)-186.49%

EPS NY rev (3m)-178.95%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-57.74%

Revenue NY rev (1m)-44.63%

Revenue NY rev (3m)-44.83%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.67
P/FCF	N/A
P/OCF	N/A
P/B	0.16
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-3.66

EYN/A

EPS(NY)-2.09

Fwd EYN/A

FCF(TTM)-1.17

FCFYN/A

OCF(TTM)-1.17

OCFYN/A

SpS1.2

BVpS5.1

TBVpS-1.76

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-48.91%
ROE	-94.11%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	135.33%
FCFM	N/A

ROA(3y)-25.19%

ROA(5y)-19.15%

ROE(3y)-40.45%

ROE(5y)-30.57%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y9.58%

GM growth 5Y4.65%

F-Score3

Asset Turnover0.12

Health

		Industry Rank	Sector Rank
Debt/Equity	0.48
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	0.5%
Cap/Sales	0.31%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.59
Quick Ratio	0.59
Altman-Z	-2.86

F-Score3

WACC10.35%

ROIC/WACCN/A

Cap/Depr(3y)2.47%

Cap/Depr(5y)7.52%

Cap/Sales(3y)0.99%

Cap/Sales(5y)1.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)8.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-236.67%

EPS Next Y-41.64%

EPS Next 2Y4.25%

EPS Next 3Y3.79%

EPS Next 5YN/A

Revenue 1Y (TTM)-53.48%

Revenue growth 3Y-39.84%

Revenue growth 5Y-27.67%

Sales Q2Q%-41.42%

Revenue Next Year-38.17%

Revenue Next 2Y4.54%

Revenue Next 3Y-9.31%

Revenue Next 5YN/A

EBIT growth 1Y46.39%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year104.69%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y21.43%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y18.74%

OCF growth 3YN/A

OCF growth 5YN/A

XCEL BRANDS INC / XELB FAQ

What is the fundamental rating for XELB stock?

ChartMill assigns a fundamental rating of 1 / 10 to XELB.

What is the valuation status of XCEL BRANDS INC (XELB) stock?

ChartMill assigns a valuation rating of 0 / 10 to XCEL BRANDS INC (XELB). This can be considered as Overvalued.

What is the profitability of XELB stock?

XCEL BRANDS INC (XELB) has a profitability rating of 1 / 10.

Can you provide the financial health for XELB stock?

The financial health rating of XCEL BRANDS INC (XELB) is 2 / 10.

What is the expected EPS growth for XCEL BRANDS INC (XELB) stock?

The Earnings per Share (EPS) of XCEL BRANDS INC (XELB) is expected to decline by -41.64% in the next year.

XCEL BRANDS INC (XELB) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

XCEL BRANDS INC / XELB FAQ

What is the fundamental rating for XELB stock?

What is the valuation status of XCEL BRANDS INC (XELB) stock?

What is the profitability of XELB stock?

Can you provide the financial health for XELB stock?

What is the expected EPS growth for XCEL BRANDS INC (XELB) stock?